Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies

Biochemical Pharmacology

Volumn 86, Issue 8, 2013, Pages 1054-1062

  Pandya, Anshul A ^a   Yakel, Jerrel L ^b  

^a UNIVERSITY OF ALASKA FAIRBANKS   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Allosteric modulation; Animal behavioral studies; Cognition; Nicotinic acetylcholine receptor; Pain; Positive allosteric modulators

Indexed keywords

EID: 84885652983     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.05.018     Document Type: Review

References (126)

1. Arias HR. Biological and biophysical aspects of ligand-gated ion channel receptor superfamilies. Kerala, India: Research Signpost; 2006.
2. BramsM, Pandya A, Kuzmin D, van Elk R, Krijnen L, Yakel JL, et al. A structural and mutagenic blueprint for molecular recognition of strychnine and dtubocurarine by different cys-loop receptors. PLoS Biol 2011;9:e1001034.
3. Arneric SP, Brioni JD. Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. New York: Wiley-Liss; 1999.
4. Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 2006;27:482-91. (Pubitemid 44251225)
5. Paldi-Haris P, Szelenyi JG, Nguyen TH, Hollan SR. Changes in the expression of the cholinergic structures of human T lymphocytes due to maturation and stimulation. Thymus 1990;16:119-22. (Pubitemid 20322425)
6. Bruno R, Sabater L, Tolosa E, Sospedra M, Ferrer-Francesch X, Coll J, et al. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus. J Neuroimmunol 2004;149:147-59. (Pubitemid 38352868)
7. Grando SA. Receptor-mediated action of nicotine in human skin. Int J Dermatol 2001;40:691-3. (Pubitemid 34023638)
8. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 1998;287:435-9. (Pubitemid 29140230)
9. Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, Macklin K, et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 1998;54:779-88. (Pubitemid 28523170)
10. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 1992;41:31-7.
11. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, et al. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J Pharmacol Exp Ther 1996;276:289-97. (Pubitemid 26150970)
12. Pandya A, Yakel JL. Allosteric modulators of the alpha4beta2 subtype of neuronal nicotinic acetylcholine receptors. Biochem Pharmacol 2011;82:952-8.
13. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Ion Channels 1996;4:377-450.
14. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 1996;109:125-37. (Pubitemid 27047080)
15. Whiting PJ, Schoepfer R, Swanson LW, Simmons DM, Lindstrom JM. Functional acetylcholine receptor in PC12 cells reacts with amonoclonal antibody to brain nicotinic receptors. Nature 1987;327:515-8. (Pubitemid 17085819)
16. Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, et al. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci 2009;29:918-29.
17. Khiroug SS, Harkness PC, Lamb PW, Sudweeks SN, Khiroug L, Millar NS, et al. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-Assemble to form functional heteromeric nicotinic receptor channels. J Physiol 2002;540:425-34. (Pubitemid 35190121)
18. Liu Q, Huang Y, Shen J, Steffensen S, Wu J. Functional alpha7beta2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid beta peptides. BMC Neurosci 2013;13:155.
19. Fucile S, Sucapane A, Eusebi F. Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones. J Physiol 2005;565:219-28. (Pubitemid 40723704)
20. Fayuk D, Yakel JL. Dendritic Ca2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons. J Physiol 2007;582:597-611. (Pubitemid 47040547)
21. Fayuk D, Yakel JL. Ca2+ permeability of nicotinic acetylcholine receptors in rat hippocampal CA1 interneurones. J Physiol 2005;566:759-68. (Pubitemid 41122659)
22. Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of alpha4-beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 1998;54:1124-31. (Pubitemid 29002058)
23. Khiroug SS, Khiroug L, Yakel JL. Rat nicotinic acetylcholine receptor alpha2-beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes. Neuroscience 2004;124:817-22. (Pubitemid 38328771)
24. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 1997;280:346-56. (Pubitemid 27171421)
25. Carbone AL, Moroni M, Groot-Kormelink PJ, Bermudez I. Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol 2009;156:970-81.
26. Moroni M, Zwart R, Sher E, Cassels BK, Bermudez I. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-Term exposure to nicotine. Mol Pharmacol 2006;70:755-68. (Pubitemid 44092336)
27. Radcliffe KA, Dani JA. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 1998;18:7075-83. (Pubitemid 28425795)
28. Horiguchi K, Horiguchi S, Yamashita N, Irie K, Masuda J, Takano-Ohmuro H, et al. Expression of SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, in murine bronchial epithelial cells. J Neurosci Res 2009;87:2740-7.
29. Koval L, Lykhmus O, Kalashnyk O, Bachinskaya N, Kravtsova G, Soldatkina M, et al. The presence and origin of autoantibodies against alpha4 and alpha7 nicotinic acetylcholine receptors in the human blood: possible relevance to Alzheimer's pathology. J Alzheimers Dis 2011;25:747-61.
30. Chang B, Daniele CA, Gallagher K, Madonia M, Mitchum RD, Barrett L, et al. Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol 2011;106:801-8.
31. Mok MH, Kew JN. Excitation of rat hippocampal interneurons via modulation of endogenous agonist activity at the alpha7 nicotinic ACh receptor. J Physiol 2006;574:699-710. (Pubitemid 44089068)
32. Gu Z, Yakel JL. Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity. Neuron 2011;71:155-65.
33. Parri HR, Hernandez CM, Dineley KT. Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochem Pharmacol 2011;82:931-42.
34. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004;74:363-96. (Pubitemid 40092737)
35. McGehee DS. Nicotine and synaptic plasticity in prefrontal cortex. Sci STKE 2007;2007:pe44.
36. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998;391:173-7.
37. Picciotto MR, Corrigall WA. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 2002;22:3338-41. (Pubitemid 37465738)
38. Pandya A, Yakel JL. Allosteric modulator Desformylflustrabromine relieves the inhibition of alpha2beta2 and alpha4beta2 nicotinic acetylcholine receptors by beta-Amyloid(1-42) peptide. J Mol Neurosci 2011;45:42-7.
39. Maelicke A, Albuquerque EX. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. Eur J Pharmacol 2000;393:165-70. (Pubitemid 30193413)
40. Kuryatov A, Gerzanich V, Nelson M, Olale F, Lindstrom J. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J Neurosci 1997;17:9035-47. (Pubitemid 27498431)
41. Marini C, Guerrini R. The role of the nicotinic acetylcholine receptors in sleeprelated epilepsy. Biochem Pharmacol 2007;74:1308-14. (Pubitemid 47417923)
42. Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-6. (Pubitemid 36521203)
43. Hogg RC, Raggenbass M, Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 2003;147:1-46.
44. Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 2004;174:54-64. (Pubitemid 38925091)
45. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 1992;587:130-6.
46. Freedman R, Wetmore C, Stromberg I, Leonard S, Olson L. Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci 1993;13: 1965-75. (Pubitemid 23113409)
47. Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK. Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 2004;123:81-90. (Pubitemid 38392067)
48. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002;125:1483-95. (Pubitemid 34755164)
49. Ray MA, Graham AJ, Lee M, Perry RH, Court JA, Perry EK. Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus. Neurobiol Dis 2005;19:366-77. (Pubitemid 40968050)
50. Bailey CD, De Biasi M, Fletcher PJ, Lambe EK. The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci 2010;30:9241-52.
51. Rezvani AH, Kholdebarin E, Cauley MC, Dawson E, Levin ED. Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats. Pharmacol Biochem Behav 2009;92:141-6.
52. Hoyle E, Genn RF, Fernandes C, Stolerman IP. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) 2006;189:211-23. (Pubitemid 44691543)
53. Terry Jr. AV, Risbrough VB, Buccafusco JJ, Menzaghi F. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. J Pharmacol Exp Ther 2002;301: 284-92. (Pubitemid 34250306)
54. Pandya AA, Yakel JL. Activation of the alpha7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT(1a) receptor antagonist. Neuropharmacology 2013;70C:35-42.
55. Levin ED, Simon BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 1998;138:217-30. (Pubitemid 28365487)
56. Munro G, Hansen R, Erichsen H, Timmermann D, Christensen J, Hansen H. The alpha7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat. Br J Pharmacol 2012;167:421-35.
57. Zhang J, Xiao YD, Jordan KG, Hammond PS, Van Dyke KM, Mazurov AA, et al. Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of alpha4beta2 receptors. Eur J Pharm Sci 2012;47:813-23.
58. Costa R, Motta EM, Manjavachi MN, Cola M, Calixto JB. Activation of the alpha-7 nicotinic acetylcholine receptor (alpha7 nAchR) reverses referred mechanical hyperalgesia induced by colonic inflammation in mice. Neuropharmacology 2012;63:798-805.
59. Freitas K, Negus SS, Carroll FI, Damaj MI. In vivo pharmacological interactions between a type ii positive allosteric modulator of alpha7 nicotinic acetylcholine receptors and nicotinic agonists in a murine tonic pain model. Br J Pharmacol 2012;169:567-79.
60. Freitas K, Carroll FI, Damaj MI. The antinociceptive effects of nicotinic receptors alpha7-positive allosteric modulators in murine acute and tonic pain models. J Pharmacol Exp Ther 2013;344:264-75.
61. Freitas K, Ghosh S, Ivy Carroll F, Lichtman AH, Imad Damaj M. Effects of alpha 7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models. Neuropharmacology 2013;65:156-64.
62. Rode F, Munro G, Holst D, Nielsen EO, Troelsen KB, Timmermann DB, et al. Positive allosteric modulation of alpha4beta2 nAChR agonist induced behaviour. Brain Res 2012;1458:67-75.
63. Zhu CZ, Chin CL, Rustay NR, Zhong C, Mikusa J, Chandran P, et al. Potentiation of analgesic efficacy but not side effects: co-Administration of an alpha4beta2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats. Biochem Pharmacol 2011;82:967-76.
64. Lee CH, Zhu C, Malysz J, Campbell T, Shaughnessy T, Honore P, et al. alpha4-beta2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of alpha4beta2 nAChR agonists in pain. Biochem Pharmacol 2011;82:959-66.
65. Timmermann DB, Sandager-Nielsen K, Dyhring T, Smith M, Jacobsen AM, Nielsen EO, et al. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of alpha2-And alpha4-containing nicotinic acetylcholine receptors. Br J Pharmacol 2012;167:164-82.
66. File SE, Kenny PJ, Ouagazzal AM. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 1998;112:1423-9. (Pubitemid 29052629)
67. Roni MA, Rahman S. Neuronal nicotinic receptor antagonist reduces anxietylike behavior in mice. Neurosci Lett 2011;504:237-41.
68. Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 2002;13:1097-106. (Pubitemid 34722033)
69. Salas R, Pieri F, Fung B, Dani JA, De Biasi M. Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci 2003;23:6255-63. (Pubitemid 36875627)
70. Hayase T. Chronologically overlapping occurrences of nicotine-induced anxiety-And depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. BMC Neurosci 2007;8:76.
71. Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, et al. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety-And depression-like behavior. Proc Natl Acad Sci USA 2013;110:3573-8.
72. Chang YC, Wu W, Zhang JL, Huang Y. Allosteric activation mechanism of the cys-loop receptors. Acta Pharmacol Sin 2009;30:663-72.
73. Taly A, Corringer PJ, Grutter T, Prado de Carvalho L, Karplus M, Changeux JP. Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 2006;103:16965-70. (Pubitemid 44737361)
74. Edelstein SJ, Schaad O, Henry E, Bertrand D, Changeux JP. A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions. Biol Cybern 1996;75:361-79. (Pubitemid 126676898)
75. Lena C, Changeux JP. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci 1993;16:181-6. (Pubitemid 23105324)
76. Grosman C, Auerbach A. The dissociation of acetylcholine from open nicotinic receptor channels. Proc Natl Acad Sci USA 2001;98:14102-07. (Pubitemid 33116031)
77. Hille B. Ion channels of excitable membranes. Sunderland, Mass: Sinauer; 2001.
78. Bertrand D, Gopalakrishnan M. Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol 2007;74:1155-63. (Pubitemid 47417931)
79. Paradiso K, Zhang J, Steinbach JH. The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid. J Neurosci 2001;21:6561-8. (Pubitemid 32781100)
80. Kim JS, Padnya A, Weltzin M, Edmonds BW, Schulte MK, Glennon RA. Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator. Bioorg Med Chem Lett 2007;17: 4855-60. (Pubitemid 47187695)
81. German N, Kim JS, Jain A, Dukat M, Pandya A, Ma Y, et al. Deconstruction of the alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine. J Med Chem 2011;54:7259-67.
82. Collins T, Young GT, Millar NS. Competitive binding at a nicotinic receptor transmembrane site of two alpha7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization. Neuropharmacology 2011;61:1306-13.
83. Henderson BJ, Pavlovicz RE, Allen JD, Gonzalez-Cestari TF, Orac CM, Bonnell AB, et al. Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors. J Pharmacol Exp Ther 2011;334:761-74.
84. Young GT, Zwart R, Walker AS, Sher E, Millar NS. Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc Natl Acad Sci USA 2008;105:14686-91.
85. Arias HR, Gu RX, Feuerbach D, Guo BB, Ye Y, Wei DQ. Novel positive allosteric modulators of the human alpha7 nicotinic acetylcholine receptor. Biochemistry 2011;50:5263-78.
86. Pavlovicz RE, Henderson BJ, Bonnell AB, Boyd RT, McKay DB, Li C. Identification of a negative allosteric site on human alpha4beta2 and alpha3beta4 neuronal nicotinic acetylcholine receptors. PLoS ONE 2011;6:e24949.
87. Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 2009;8:733-50.
88. Changeux JP, Taly A. Nicotinic receptors, allosteric proteins and medicine. Trends Mol Med 2008;14:93-102.
89. Romanelli MN, Gualtieri F. Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications. Med Res Rev 2003;23:393-426. (Pubitemid 36706510)
90. Whiteaker P, Sharples CG, Wonnacott S. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 1998;53:950-62. (Pubitemid 28244084)
91. Buccafusco JJ, Beach JW, Terry Jr. AV. Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. J Pharmacol Exp Ther 2009;328:364-70.
92. Lu Y, Marks MJ, Collins AC. Desensitization of nicotinic agonist-induced [3H]gamma-Aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther 1999;291:1127-34.
93. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, et al. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 2005;46:595-607.
94. Radek RJ, Robb HM, Stevens KE, Gopalakrishnan M, Bitner RS. Effects of the novel alpha7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization. J Pharmacol Exp Ther 2012;343:736-45.
95. Terry Jr. AV, Hernandez CM, Hohnadel EJ, Bouchard KP, Buccafusco JJ. Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition. CNS Drug Rev 2005;11:229-52. (Pubitemid 43100463)
96. Hajos M, Hurst RS, Hoffmann WE, Krause M, Wall TM, Higdon NR, et al. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther 2005;312:1213-22. (Pubitemid 40293783)
97. Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, et al. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther 2010;334:137-46.
98. Buccafusco JJ. Methods of behavioral analysis in neuroscience. Boca Raton: CRC Press; 2009.
99. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 2009;29:8805-15.
100. Miwa JM, Lester HA, Walz A. Optimizing cholinergic tone through lynx modulators of nicotinic receptors: implications for plasticity and nicotine addiction. Physiology (Bethesda) 2012;27:187-99.
101. Hurst RS, Hajos M, Raggenbass M, Wall TM, Higdon NR, Lawson JA, et al. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 2005;25:4396-405. (Pubitemid 40628784)
102. Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, Jow F, et al. Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b0]di pyrrole-1(2H)-carboxamide). J Pharmacol Exp Ther 2009;328:766-76.
103. Dinklo T, Shaban H, Thuring JW, Lavreysen H, Stevens KE, Zheng L, et al. Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4- pyridinyl)-5-Thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor. J Pharmacol Exp Ther 2011;336:560-74.
104. Thomsen MS, El-Sayed M, Mikkelsen JD. Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats. PLoS ONE 2011;6:e27014.
105. McLean SL, Idris NF, Grayson B, Gendle DF, Mackie C, Lesage AS, et al. PNU-120596, a positive allosteric modulator of alpha7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats. J Psychopharmacol 2012;26:1265-70.
106. Yamada K, Takayanagi M, Kamei H, Nagai T, Dohniwa M, Kobayashi K, et al. Effects of memantine and donepezil on amyloid beta-induced memory impairment in a delayed-matching to position task in rats. Behav Brain Res 2005;162:191-9. (Pubitemid 40828531)
107. Levin ED, Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berl) 1996;123:88-97. (Pubitemid 26040256)
108. Callahan PM, Hutchings EJ, Kille NJ, Chapman JM, Terry Jr. AV. Positive allosteric modulator of alpha 7 nicotinic-Acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates. Neuropharmacology 2013;67:201-12.
109. Kohlhaas KL, Robb BR, Radek H, Markosyan RS. M. G. Improved pre-Attention and short-Term memory via positive allosteric modulation of the alpha7 neuronal nicotinic receptor. Int J Neuropsychopharmacol 2006.
110. Faghih R, Gopalakrishnan SM, Gronlien JH, Malysz J, Briggs CA, Wetterstrand C, et al. Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl- 1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor. J Med Chem 2009;52:3377-84.
111. Timmermann DB, Gronlien JH, Kohlhaas KL, Nielsen EO, Dam E, Jorgensen TD, et al. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther 2007;323:294-307. (Pubitemid 47443280)
112. Kathy L, Kohlhaas HR, Roderwald V, Markosyan S, Salte K, Bitner RS, et al. α7 NNR allosteric modulation in behavioral models of cognition. Biochem Pharmacol 2011;1042.
113. Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, et al. Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl Acad Sci USA 2007;104:8059-64. (Pubitemid 47185875)
114. Johnstone TB, Gu Z, Yoshimura RF, Villegier AS, Hogenkamp DJ, Whittemore ER, et al. Allosteric modulation of related ligand-gated ion channels synergistically induces long-Term potentiation in the hippocampus and enhances cognition. J Pharmacol Exp Ther 2010;336:908-15.
115. Khan IM, Buerkle H, Taylor P, Yaksh TL. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology 1998;37:1515-25. (Pubitemid 28550425)
116. van Maanen MA, Lebre MC, van der Poll T, LaRosa GJ, Elbaum D, Vervoordeldonk MJ, et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009;60:114-22.
117. Broad LM, Zwart R, Pearson KH, Lee M, Wallace L, McPhie GI, et al. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. J Pharmacol Exp Ther 2006;318:1108-17. (Pubitemid 44268317)
118. Yoshimura RF, Hogenkamp DJ, Li WY, Tran MB, Belluzzi JD, Whittemore ER, et al. Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-Administration in rats. J Pharmacol Exp Ther 2007;323:907-15. (Pubitemid 350146068)
119. Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 1992;89:9949-53.
120. Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM. Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol Sci 2005;26:352-60. (Pubitemid 40848496)
121. French KL, Bimonte-Nelson HA, Granholm AC. Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats. Cell Transplant 2007;16:197-205. (Pubitemid 47300227)
122. Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology 2005;30:2135-43. (Pubitemid 41643964)
123. Levandoski MM, Piket B, Chang J. The anthelmintic levamisole is an allosteric modulator of human neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 2003;471:9-20. (Pubitemid 36694854)
124. WuTY, Smith CM, Sine SM, Levandoski MM.Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors. Mol Pharmacol 2008;74:466-75.
125. Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, Gundisch D, et al. Nicotine decreases food intake through activation of POMC neurons. Science 2011;332:1330-2.
126. Mineur YS, Einstein EB, Seymour PA, Coe JW, O'Neill BT, Rollema H, et al. alpha4beta2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties. Behav Pharmacol 2011;22:291-9.